https://www.coltonconsortium.org/directory/james-hoxie-md/
Emeritus Professor, Department of Medicine (Hematology-Oncology), Perelman School of Medicine, University of Pennsylvania Dr. James Hoxie is Emeritus Professor of Medicine in the Division of Hematology-Oncology and Co-Director of the […]
https://www.coltonconsortium.org/directory/jill-p-buyon-md/
Sir Deryck and Lady Va Maughan Professor of Rheumatology, Department of Medicine, NYU Grossman School of Medicine / NYU Langone Health Director, Division of Rheumatology, NYU Grossman School of Medicine […]
https://www.coltonconsortium.org/directory/e-john-wherry-phd/
Chair & Richard and Barbara Schiffrin President’s Distinguished Professor, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania Director, Colton Consortium for Autoimmunity Director, Colton […]
https://www.coltonconsortium.org/directory/ali-naji-md-phd/
Jonathan E. Rhoads Professor of Surgical Science II, Department of Surgery, Perelman School of Medicine, University of Pennsylvania Dr. Ali Naji is the J. William White Professor of Surgical Research […]
https://www.coltonconsortium.org/directory/amit-bar-or-md-frcp-faan-fana/
Melissa and Paul Anderson President’s Distinguished Professor, Department of Neurology, Perelman School of Medicine, University of Pennsylvania Dr. Amit Bar-Or is the inaugural Melissa and Paul Anderson President’s Distinguished Professor […]
https://www.coltonconsortium.org/directory/benjamin-abramoff-md-ms/
Associate Professor, Department of Physical Medicine and Rehabilitation, Perelman School of Medicine, University of Pennsylvania Dr. Benjamin Abramoff is an Assistant Professor of Physical Medicine and Rehabilitation at the Perelman […]
https://www.coltonconsortium.org/projects/targeted-biologic-therapy-for-autoimmune-disease-associated-with-dnaseil3-deficiency/
Developing a bioavailable DNAseIL3 biologic to degrade pathogenic autoantibodies and treat lupus and related autoimmune diseases.
https://www.coltonconsortium.org/projects/inhibiting-netosis-with-nuclear-penetrating-antibodies/
Repurposing nuclear-penetrating autoantibodies from lupus and scleroderma patients as potent, safe inhibitors of pathogenic NETosis.
https://www.coltonconsortium.org/projects/ai-simulated-in-silico-humans-a-new-paradigm-for-modeling-autoimmunity/
Building AI-powered digital avatars that simulate each patient's immune system to predict therapy response and accelerate precision immunotherapy development.
https://www.coltonconsortium.org/projects/penn-chop-immune-kidney-disease-collaboratory/
Building a spatial single-cell atlas of healthy and diseased human kidneys to redefine immune-mediated kidney disease and identify precision diagnostic and therapeutic targets.